Pharma companies less concerned after hearing from US on negotiated prices for MedicareReuters • 07/29/24
Is Bristol-Myers Squibb's Stock Rally Justified? Bull Vs. Bear Analysts On Q2 EarningsBenzinga • 07/29/24
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend YieldsBenzinga • 07/29/24
This Bristol-Myers Squibb Analyst Turns Bearish; Here Are Top 5 Downgrades For MondayBenzinga • 07/29/24
Bristol Myers Squibb Shows Resilience Amid Patent Expiry Challenges (Rating Upgrade)Seeking Alpha • 07/28/24
Bristol Myers Retakes Its 200-Day Line On Quarterly Beat, Surprise Immunology WinInvestors Business Daily • 07/26/24
Bristol-Myers Squibb Beats Q2 Expectations, Boosts Guidance on Rising Drug SalesInvestopedia • 07/26/24
Bristol Myers (BMY) Q2 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 07/26/24
Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Surpass EstimatesZacks Investment Research • 07/26/24